Skip to content

CARIS LIFE SCIENCES, INC.

CAI

CIK 0002019410

← back to feed
Revenue (TTM)
$735.32M
+97.0% YoY Q1 May 2026
Net Income (TTM)
−$150.56M
+75.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$11.46
+69.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-5.2%
Q1 May 2026
Net Margin
-20.5%
Q1 May 2026
Free Cash Flow (TTM)
$66.9M
Q1 May 2026
Cash
$819.9M
Q1 May 2026
Total Debt
$381.58M
Q1 May 2026
Shares Outstanding
282.68M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings